Drug Type Non-recombinant coagulation factor |
Synonyms- |
Action modulators |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (02 Dec 2020), |
Regulation- |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hemorrhage | China | 02 Dec 2020 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Deficiency Diseases | Preclinical | China | 03 Aug 2017 | |
| Hemophilia B | Preclinical | China | 03 Aug 2017 |






